Preparing for an AI future that’s already here
Few foresaw the impact OpenAI’s ChatGPT would have just 2.5 years ago. Yet GenAI has already begun disrupting entire industries and new technology breakthroughs are emerging at pace. As new iterations push the boundaries of deep research and insight generation, the implications for life sciences are both profound and uncertain. ArisGlobal’s Jason Bryant considers how the biopharma industry can best prepare for an undefined future that is already unfolding.